Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
ClinicalTrials.gov study NCT01736683. IPD Sharing: YES. Countries: 2. Publications: 1.
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
ClinicalTrials.gov study NCT00025662. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00961064. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
ClinicalTrials.gov study NCT02367456. IPD Sharing: NO. Countries: 6. Publications: 1.
Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04313881. IPD Sharing: NO. Countries: 21. Publications: 1.
Extension Study to Evaluate Long-Term Effects of Luspatercept in Patients With Myelodysplastic Syndromes (MDS) (A536-05/MK-6143-003)
ClinicalTrials.gov study NCT02268383. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
ClinicalTrials.gov study NCT01029262. IPD Sharing: Not stated. Countries: 16. Publications: 3.
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
ClinicalTrials.gov study NCT02730299. IPD Sharing: NO. Countries: 10. Publications: 4.
Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia
ClinicalTrials.gov study NCT00867308. IPD Sharing: NO. Countries: 1. Publications: 1.
Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
ClinicalTrials.gov study NCT07400341. IPD Sharing: YES. Countries: 1. Publications: 12.
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00948064. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia
ClinicalTrials.gov study NCT04324060. IPD Sharing: YES. Countries: 1. Publications: 1.
SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01261312. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00619099. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
ClinicalTrials.gov study NCT02921061. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00067808. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01201811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
ClinicalTrials.gov study NCT05184842. IPD Sharing: NO. Countries: 1. Publications: 1.
Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02599649. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
ClinicalTrials.gov study NCT00088218. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.